Wheat Bread Study: Comparison of the Tolerance of Different Wheat Breads

NCT ID: NCT06152445

Last Updated: 2024-05-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

64 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-19

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to assess the differences in tolerability of differently manufactured wheat breads in a target group of individuals with suspected wheat sensitivity. Additionally, it will be verified, if the absence of a response to oral exposure to defined bread types is associated with an absence of mucosal changes following CLE-assisted mucosal provocation with bread.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Nowadays, more than 20% of people in industrialized countries suffer from a food intolerance or food allergy, with wheat and gluten intolerances on the rise. Besides the well-known conditions celiac disease and wheat allergy, another clinical entity called non-celiac wheat sensitivity (NCWS) was described, which is not yet widely understood. Resulting from inconsistent diagnostic criteria the prevalence of NCWS varies from 0.5% to 13%.

Due to the lack of validated diagnostic criteria and/or appropriate biomarkers for diagnosis of NCWS, it can currently only be suspected by exclusion of other diseases. To verify suspected NCWS, a double-blind placebo-controlled food challenge with wheat is recommended. A confocal laser endomicroscopy (CLE) with endoluminal provocation can also provide meaningful results on the individual intestinal mucosal response to specific allergens.

Furthermore, it is as yet unclear whether NCWS is triggered by gluten, FODMAPs, or other wheat components such as α-amylase trypsin inhibitors. Bread manufacturing processes can influence the composition of bread and the presence of possible triggers of intolerance reactions.

This study aims to investigate the tolerability of differently manufactured wheat breads in individuals with suspected NCWS. Additionally, we expect this approach to improve the currently inadequate diagnosis of NCWS, as well as to provide a better understanding of the underlying mechanisms.

Therefore, individuals with suspected NCWS are included in the trial. Five different types of bread will be tested, including 3 differently manufactured wheat breads, a gluten free bread and a gluten free bread with added wheat flour. Aim of this part is to test a possible psychological factor in NCWS symptoms.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Non-celiac Gluten Sensitivity Wheat Hypersensitivity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Gluten free bread

Bread will be eaten by the participants for 7 consecutive days

Group Type PLACEBO_COMPARATOR

Wheat bread

Intervention Type OTHER

Different wheat breads

Gluten free bread with added wheat flour

Bread will be eaten by the participants for 7 consecutive days

Group Type ACTIVE_COMPARATOR

Wheat bread

Intervention Type OTHER

Different wheat breads

Wheat bread with Yeast, short fermentation + bread improver

Bread will be eaten by the participants for 7 consecutive days

Group Type EXPERIMENTAL

Wheat bread

Intervention Type OTHER

Different wheat breads

Wheat bread with Yeast, long fermentation

Bread will be eaten by the participants for 7 consecutive days

Group Type EXPERIMENTAL

Wheat bread

Intervention Type OTHER

Different wheat breads

Wheat bread with Sourdough, long fermentation

Bread will be eaten by the participants for 7 consecutive days

Group Type EXPERIMENTAL

Wheat bread

Intervention Type OTHER

Different wheat breads

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Wheat bread

Different wheat breads

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 ≤75 years
* Signed declaration of consent
* Willingness to adhere to the prescribed diet for the duration of the study
* Chronic gastrointestinal symptoms for at least 6 months
* Anamnestic wheat sensitivity
* No acute or chronic gastrointestinal diseases (e.g. celiac disease / wheat allergy)
* No or stable medication for at least 3 months
* No participation in another clinical trial (current or within the past 30 days)

Exclusion Criteria

* Taking intestinal therapeutics, antibiotics, immunosuppressants, anti-allergic medication or similar
* Pregnancy / lactation
* Occurrence of relevant diseases (possibly individual decision)
* Revocation of consent
* Concurrent participation in another clinical study
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital Schleswig-Holstein

OTHER

Sponsor Role collaborator

University of Hohenheim

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Stephan C. Bischoff, MD, Professor

Professor Dr. med.

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Institute of Nutritional Medicine, University of Hohenheim

Stuttgart, Baden-Wurttemberg, Germany

Site Status RECRUITING

Institute of Nutritional Medicine, University Hospital Schleswig Holstein, Campus Lübeck

Lübeck, Schleswig-Holstein, Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Stephan C Bischoff, Prof.Dr

Role: CONTACT

071145924101

Patricia P Petersen, M.Sc

Role: CONTACT

071145923622

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Stephan C Bischoff, Prof. Dr.

Role: primary

0711 459 24101

Patricia P Petersen, M.Sc.

Role: backup

0711 459 23622

Christian Sina, Prof. Dr.

Role: primary

0451 3101 8401

Ina Hohensee, Dr.

Role: backup

0451 3101 8424

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ErnMed-Brot-2022

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Gluten Challenge in Celiac Disease
NCT02464150 COMPLETED NA
Serum Markers in Gluten Challenge
NCT00931892 COMPLETED NA
Gluten Sensitivity in Non-Celiac Patients
NCT01485341 COMPLETED PHASE3